Skip to content

Clinical trials

Observational Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Observational Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20051
20063
20073
20092
20105
20115
20124
20133
20145
20153
20164
20173
20182
20194
20205
20213
20227
20237
20246
202512
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting21
Unknown status19
Terminated4
Active, not recruiting4
Withdrawn4
Enrolling by invitation4
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University6
AstraZeneca3
European Institute of Oncology3
Mayo Clinic3
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
Memorial Sloan Kettering Cancer Center2
Royal Marsden NHS Foundation Trust2
St. James's Hospital, Ireland2
University Hospital, Bordeaux2
University Hospital, Gasthuisberg2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma101
Prostatic Neoplasms33
Carcinoma17
Neoplasms17
Carcinoma, Squamous Cell13
Carcinoma, Non-Small-Cell Lung9
Esophageal Neoplasms8
Lung Neoplasms8
Pancreatic Neoplasms8
Sarcoma7

Trials

Showing 26 to 50 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.